Zymeworks is thrilled to announce that Dr. Raffaele Colombo has been honored as a PharmaVoice 100 winner. This annual list recognizes the most inspiring people in the life sciences industry.
Dr. Colombo has been instrumental in the advancement of Zymeworks’ wholly-owned pipeline, leveraging his experience and knowledge towards the development of a portfolio of novel antibody-drug conjugate (ADC) candidates designed to balance efficacy and tolerability. His leadership also extends well beyond the lab, earning him recognition as a sought-after collaborator and speaker at major industry conferences. His contributions to Zymeworks and the ADC field have strengthened our position as a leader in multifunctional drug development, while inspiring the next generation of scientists in the life sciences.
“Dr. Colombo has been an integral part of our ADC Therapeutics Development team, and this recognition is well-deserved. With 15 years of dedicated experience in drug conjugates, he has demonstrated an exceptional understanding of the intricacies and nuances that make this field so challenging and rewarding,” said Paul Moore, Ph.D., Chief Scientific Officer at Zymeworks. “Dr. Colombo’s passion for advancing ADCs is evident in every project, and his commitment to pushing the boundaries of innovation continues to inspire the entire team. Congratulations on this remarkable achievement!”
PharmaVoice100 honorees are selected from a pool of nominations submitted by readers and colleagues, evaluated by the PharmaVoice team, then categorized into 10 distinct groups: Standout Leaders, Cancer Care Visionaries, Cardiometabolic All-Stars, Trailblazers, Biotech Pathfinders, Rare Disease Warriors, Tech and AI Wizards, Clinical Trial Pros, Patient Champions, and Cell and Gene Therapy Pioneers. Each winner represents the transformative impact of the pharmaceutical industry in their own unique way. Since 2005, the PharmaVoice 100 has become one of the publication’s most anticipated features. From academia and nonprofits to Big Pharma, startups and tech companies, it is the only awards program in the industry that honors individuals from all sectors of life sciences. These honorees, from the clinic to the C-suite, are making meaningful contributions to their fields and striving to improve outcomes for patients around the world.
